Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...

(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

The following letter from the American Health Care Association and National Center for Assisted Living was sent to the National Governors Association and state governors ...

Trump's executive orders for the Pentagon will fulfill campaign promises that the Republican reiterated during last week's ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

George Rodrique sued Hearst Stations and Hearst Communications, WCVB’s owner, in late 2022 over his termination the year ...

After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.”  | The company benefited from higher-than-expected sales of ...